The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis

Hormone Research in Paediatrics

Volumn 80, Issue 6, 2014, Pages 449-456

  Malaquias, Alexsandra C ^a   Scalco, Renata C ^a   Fontenele, Eveline G P ^b   Costalonga, Everlayny F ^c   Baldin, Alexandre D ^d   Braz, Adriana F ^a   Funari, Mariana F A ^a   Nishi, Mirian Y ^a   Guerra Junior, Gil ^d   Mendonca, Berenice B ^a   Arnhold, Ivo J P ^a   Jorge, Alexander A L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSIDADE VILA VELHA   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Idiopathic short stature; L ri Weill dyschondrosteosis; SHOX gene; Turner syndrome

Indexed keywords

ADOLESCENT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; DYSCHONDROSTEOSIS; FEMALE; GENE; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC SHORT STATURE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX; SHORT STATURE; SHORT STATURE HOMEOBOX CONTAINING GENE; SHORT STATURE HOMEOBOX CONTAINING GENE DEFECT; SITTING; SITTING HEIGHT HEIGHT RATIO FOR AGE; TURNER SYNDROME; ADULT; HAPLOINSUFFICIENCY; SCORING SYSTEM; SHOX GENE;

ADOLESCENT; ADULT; AGE FACTORS; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GROWTH DISORDERS; HOMEODOMAIN PROTEINS; HUMANS; MALE; PATIENT SELECTION; PHENOTYPE; POSTURE; TURNER SYNDROME;

EID: 84893127903     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000355411     Document Type: Article

References (28)

1. Ellison JW, Wardak Z, Young MF, Gehron Robey P, Laig-Webster M, Chiong W: PHOG, a candidate gene for involvement in the short stature of turner syndrome. Hum Mol Genet 1997; 6: 1341-1347.
2. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA: Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997; 16: 54-63.
3. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA: The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000; 9: 695-702.
4. Ross JL, Kowal K, Quigley CA, Blum WF, Cutler GB Jr, Crowe B, Hovanes K, Elder FF, Zinn AR: The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: Contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr 2005; 147: 499-507.
5. Neufeld ND, Lippe BM, Kaplan SA: Disproportionate growth of the lower extremities. A major determinant of short stature in Turner's syndrome. Am J Dis Child 1978; 132: 296-298.
6. Rongen-Westerlaken C, Rikken B, Vastrick P, Jeuken AH, de Lange MY, Wit JM, van der Tweel L, Van den Brande JL: Body proportions in individuals with Turner syndrome. The Dutch growth hormone working group. Eur J Pediatr 1993; 152: 813-817.
7. Gravholt CH, Weis Naeraa R: Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome. Am J Med Genet 1997; 72: 403-408.
8. Baldin AD, Armani MC, Morcillo AM, Lemos-Marini SH, Baptista MT, Maciel-Guerra AT, Guerra-Junior G: Body proportions in a group of Brazilian patients with Turner syndrome. Arq Bras Endocrinol Metabol 2005; 49: 529-535.
9. Jorge AA, Funari MF, Nishi MY, Mendonca BB: Short stature caused by isolated SHOX gene haploinsufficiency: Update on the diagnosis and treatment. Pediatr Endocrinol Rev 2010; 8: 79-85.
10. Ross JL, Scott C Jr, Marttila P, Kowal K, Nass A, Papenhausen P, Abboudi J, Osterman L, Kushner H, Carter P, Ezaki M, Elder F, Wei F, Chen H, Zinn AR: Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001; 86: 5674-5680.
11. Binder G, Ranke MB, Martin DD: Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in schoolage children with unexplained short stature. J Clin Endocrinol Metab 2003; 88: 4891-4896.
12. Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA, Ross JL, Niesler B: Genotypes and phenotypes in children with short stature: Clinical indicators of SHOX haploinsufficiency. J Med Genet 2007; 44: 306-313.
13. Jorge AA, Souza SC, Nishi MY, Billerbeck AE, Liborio DC, Kim CA, Arnhold IJ, Mendonca BB: SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: Frequency and phenotypic variability. Clin Endocrinol (Oxf) 2007; 66: 130-135.
14. Hirschfeldova K, Solc R, Baxova A, Zapletalova J, Kebrdlova V, Gaillyova R, Prasilova S, Soukalova J, Mihalova R, Lnenicka P, Florianova M, Stekrova J: SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Leri-Weill dyschondrosteosis. Gene 2012; 491: 123-127.
15. Kant SG, Broekman SJ, de Wit CC, Bos M, Scheltinga SA, Bakker E, Oostdijk W, van der Kamp HJ, van Zwet EW, van der Hout AH, Wit JM, Losekoot M: Phenotypic characterization of patients with deletions in the 3 ′ -flanking SHOX region. PeerJ 2013; 1:e35.
16. Fredriks AM, van Buuren S, van Heel WJ, Dijkman-Neerincx RH, Verloove-Vanhorick SP, Wit JM: Nationwide age references for sitting height, leg length, and sitting height/ height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child 2005; 90: 807-812.
17. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data 2000; 314: 1-27.
18. Silva DA, Pelegrini A, Petroski EL, Gaya AC: Comparison between the growth of Brazilian children and adolescents and the reference growth charts: Data from a Brazilian project. J Pediatr (Rio J) 2010; 86: 115-120.
19. Funari MF, Jorge AA, Souza SC, Billerbeck AE, Arnhold IJ, Mendonca BB, Nishi MY: Usefulness of MLPA in the detection of SHOX deletions. Eur J Med Genet 2010; 53: 234-238.
20. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segre AV, Speliotes EK, Wheeler E, Soranzo N, Park JH, Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon Smith A, Magi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G, Winkler TW, Goddard ME, Sin Lo K, Palmer C, Workalemahu T, Aulchenko YS, Johansson A, Zillikens MC, Feitosa MF, Esko T, Johnson T, Ketkar S, Kraft P, Mangino M, Prokopenko I, Absher D, Albrecht E, Ernst F, Glazer NL, Hayward C, Hottenga JJ, Jacobs KB, Knowles JW, Kutalik Z, Monda KL, Hirschhorn JN: Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-838.
21. Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, Superti-Furga A, Scambler PJ, Winter RM: Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet 1998; 19: 70-73.
22. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V: SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 1998; 19: 67-69.
23. Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, Bettendorf M, Heinrich U, Vlachopapadoupoulou E, Reinehr T, Onigata K, Ogata T: Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002; 87: 1402-1406.
24. Jorge AA, Arnhold IJ: Anthropometric evaluation of children with SHOX mutations can be used as indication for genetic studies in children of short stature. J Med Genet 2007; 44:e90, author reply e91.
25. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, Hirano T, Terasaki H, Ohashi H, Nishimura G, Sato S, Matsuo N, Ogata T: Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: Implications for the development of turner syndrome. J Clin Endocrinol Metab 1999; 84: 4613-4621.
26. Fukami M, Nishi Y, Hasegawa Y, Miyoshi Y, Okabe T, Haga N, Nagai T, Tanaka T, Ogata T: Statural growth in 31 Japanese patients with SHOX haploinsufficiency: Support for a disadvantageous effect of gonadal estrogens. Endocr J 2004; 51: 197-200.
27. Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G: Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res 2009; 71: 167-172.
28. Scalco RC, Melo SS, Pugliese-Pires PN, Funari MF, Nishi MY, Arnhold IJ, Mendonca BB, Jorge AA: Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency. J Clin Endocrinol Metab 2010; 95: 328-332.